Bone Metabolism Tests Market Size, Share and Trends 2025 to 2034

The global bone metabolism tests market size is calculated at USD 3.13 billion in 2025 and is forecasted to reach around USD 6.02 billion by 2034, accelerating at a CAGR of 7.53% from 2025 to 2034. The North America market size surpassed USD 1.13 billion in 2024 and is expanding at a CAGR of 7.73% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : 28 Feb 2025
  • Report Code : 5613
  • Category : Healthcare

Bone Metabolism Tests Market Size and Forecast 2025 to 2034

The global bone metabolism tests market size was estimated at USD 2.91 billion in 2024 and is predicted to increase from USD 3.13 billion in 2025 to approximately USD 6.02 billion by 2034, expanding at a CAGR of 7.53% from 2025 to 2034. The global market growth is attributed to the introduction of innovative bone metabolism testing products.

Bone Metabolism Tests Market Size 2025 to 2034

Bone Metabolism Tests Market Key Takeaways

  • North America dominated the global market with the largest market share of 39% in 2024. 
  • The Asia Pacific is expected to grow fastest during the forecast period. 
  • By product, the assays or consumables segment contributed the largest market share in 2024. 
  • By product, the instruments segment is expected to expand significantly during the forecast period.  
  • By application, the vitamin D testing segment captured the biggest market share in 2024.  
  • By end-user, the hospitals segment held the largest market share in 2024. 
  • By end-user, the clinics segment is expected to grow at a rapid pace during the forecast period.

Artificial Intelligence (AI) in the Bone Metabolism Tests Market

Artificial Intelligence is used for classifying, predicting, and evaluating OP risk factors in clinical data for women and men separately. In addition, artificial intelligence was used to suggest the most effective sports programs for bone-related disease treatments. Integrating AI technologies in a clinical setting can improve treatment and help primary care providers classify patients with osteoporosis.

AI is effective in quick access and classification of bone metabolism tests. In addition, AI technologies are used to classify and predict subjects into OP, osteopenia, and healthy. AI model improves diagnostic accuracy and saves time for malignant bone diseases. Artificial intelligence offers unprecedented insights and diagnostic innovations, by artificial intelligence offers unprecedented insights and diagnostic innovations.  

  • In December 2023, an AI bone analysis tool was launched by the Royal National Orthopaedic Hospital NHS Trust that provides GPs with a patient’s risk of osteoporosis. The aim behind this launch was to be used during routine X-rays. The tool was examined for its potential to increase the very low diagnosis rates. 

U.S. Bone Metabolism Tests Market Size and Growth 2025 to 2034

The U.S. bone metabolism tests market size was exhibited at USD 850 million in 2024 and is projected to be worth around USD 1.80 billion by 2034, growing at a CAGR of 7.79% from 2025 to 2034.

U.S. Bone Metabolism Tests Market Size 2025 to 2034

North America dominated the bone metabolism tests market in 2024. The market growth in the region is attributed to the early adoption of innovative solutions, increasing robust infrastructure, and rising technological advancements. The prevalence of strong investments and major market leaders in research and development are further expected to enhance market growth in the region. The U.S. and Canada are the major dominant countries in the region. The increasing consumer preferences for advanced solutions and increased industrial applications are further anticipated to drive the growth of the market in the U.S.

Bone Metabolism Tests Market Share, By Region, 2024 (%)

The Asia Pacific is expected to grow fastest during the forecast period. The market growth in the region is attributed to the growing demand from developing countries, rapid urbanization, and industrialization. In addition, the increasing consumer demand for innovative solutions, the increasing middle-class population, and the increasing adoption of advanced technologies, equipped with increasing investments in manufacturing and infrastructure, are further expected to accelerate the growth of the bone metabolism tests market in the region. China, India, Japan, and South Korea are the major countries driving the market growth.  

Market Overview

The bone metabolism tests market deals with the functioning and health of the skeletal system. These tests help in the monitoring and evaluation of bone diseases such as bone cancer, Paget’s disease, and osteoporosis. The growing senior population across the globe, the increasing frequency of bone-related and osteoporosis diseases, and rising technological advancements in diagnostic technologies are anticipated to enhance the market growth.

In addition, the introduction of innovative bone metabolism testing products is also a major driver in enhancing the growth of the bone metabolism tests market. Various manufacturers are concentrating on developing more efficient and accurate tests to allow precise and early detection of bone-related diseases. In addition, integrating bone metabolism tests with other diagnostic modalities, including dual-energy X-ray absorptiometry (DEXA), enhances patient care and diagnostic accuracy.  

Bone Metabolism Tests Market Growth Factors

  • The increasing demand for more efficient and sustainable solutions across various industries, changing consumer preferences, and rising technological advancements are expected to drive market growth. 
  • The rise of digital technologies, such as the Internet of Things (IoT), automation, and artificial intelligence, contributed to propelling the growth of the bone metabolism tests market during the forecast period. 
  • The increasing demand for eco-friendly solutions and sustainability is expected to drive the market growth. 
  • The expanding industrial sectors, rising investments in developing markets, and government incentives and initiatives are contributing to the market growth.  
  • The demand for advanced solutions in manufacturing, automotive, healthcare, and other sectors increases as developing countries continue to modernize and industrialize.

Market Scope

Report Coverage Details
Market Size by 2034 USD 6.02 Billion
Market Size in 2025 USD 3.13 Billion
Market Size in 2024 USD 2.91 Billion
Market Growth Rate from 2025 to 2034 CAGR of 7.53%
Dominating Region North America
Fastest Growing Region Asia Pacific
Base Year 2024
Forecast Period 2025 to 2034
Segments Covered Product, Technology, Application, End-User, and Regions
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Market Dynamics

Drivers

Increasing demand for point-of-care testing

The growing demand for rapid and convenient diagnostic solutions creates lucrative opportunities for point-of-care bone metabolism tests. POC tests reduce laboratory processing time and eliminate the need for sample transportation. The quick and convenient turnaround time of point-of-care tests makes them desirable in remote settings, clinics, and emergency departments. In addition, by developing user-friendly and portable point-of-care devices for bone metabolism testing, various market leaders can capitalize on this opportunity.

Restrain

Limited reimbursement coverage

The lack of reimbursement coverage for bone metabolism tests creates major challenges to market growth. Reimbursement policies vary across healthcare systems and various countries, and some bone metabolism tests may not be reimbursed or covered fully. This can limit patient access and discourage healthcare providers from prescribing these tests. In addition, by increasing reimbursement coverage for bone metabolism tests, healthcare organizations and governments need to address this issue and ensure equitable access for patients.  

Opportunity

The rising focus on personalized medicine

The increasing trend toward personalized medicine provides lucrative opportunities for the market of bone metabolism tests. Based on individual patient characteristics, personalized medicine aims to tailor medical treatments and decisions. Personalized medicine can involve genetic testing to predict the response to specific treatments or to identify individuals at high risk of bone disorders in order to test bone metabolism tests. To integrate genetic testing with bone metabolism tests, various major companies can invest in research and development and further offer personalized treatment solutions and diagnostics.

Product Insights

The assays or consumables segment dominated the bone metabolism tests market in 2024. The market is segmented into instruments and assays or consumables. Assays or consumables include kits, reagents, and other consumable products needed for bone metabolism testing. These products are consumed with each test and necessary components of the testing procedure. In addition, consumables represent the most frequently used category of products and increased significant demand for these items from diagnostic laboratories, clinics, and medical facilities.

The instruments segment is expected to grow fastest during the forecast period. These tools include analyzers for biochemical analysis, devices for quantitative ultrasound measurement, machines that utilize dual-energy X-ray absorptiometry (DEXA), and various other equipment used for laboratory purposes or imaging.

Technology Insights

The enzyme-linked immunosorbent assay (ELISA) segment accounted for the largest market share in 2024. The market is segmented into clinical laboratory improvement amendments (CLIA), enzyme-linked immunosorbent assay (ELISA), and other tests. Due to the exceptional ability to quantify and identify various biomarkers related to the condition with a high degree of specificity and accuracy, ELISA is identified as a highly accepted method in the evaluation of bone health. In addition, these tests encompass a type of techniques such as molecular diagnostics, immunoassays, and other laboratory-based approaches that are used to assess bone metabolism. Furthermore, a range of assessment tools are available for the development of bone health, such as imaging techniques such as molecular diagnostics, genetic testing, quantitative ultrasound (QUS), and dual-energy X-ray absorptiometry.

Application Insights

The vitamin D testing segment dominated the bone metabolism tests market in 2024. The market is segmented into bone metabolism and vitamin D testing. Vitamin D testing plays an important role in bone health and includes measuring vitamin D levels in the body. In addition, the segment growth is attributed to the increasing prevalence of vitamin D insufficiency.

The bone metabolism segment is expected to grow fastest during the forecast period. In order to maintain the integrity of bone structure and bone tissue quantity, bone metabolism is characterized by an intimate cooperation of bone cells such as osteocytes, osteoclasts, and osteoblasts. Bone metabolism is regulated by osteoblastic bone formation and osteoclastic bone destruction, which investigates the interplay between the bone system and the immune system.

End-User Insights

The hospital segment dominated the bone metabolism tests market in 2024. The market is segmented into diagnostic laboratories, clinics, and hospitals. The segment growth is attributed to the increasingly high demand for bone metabolism tests in hospitals for the treatment and diagnosis of bone diseases.

  • In December 2024, Shriners Hospitals for Children Canada announced the launch of a joint genetic bone and pediatric metabolic diseases fellowship in collaboration with the CHEO Research Institute.

The clinics segment is expected to grow fastest during the forecast period. Various clinics associated with bone metabolism tests within the metabolism division and endocrinology focus on the care of patients and diagnosis of complicated, rare, or inherited bone conditions, such as skeletal dysplasias and congenital diseases, endocrine and metabolic bone diseases. 

Bone Metabolism Tests Market Companies

Bone Metabolism Tests Market Companies
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories  
  • Siemens Healthineers  
  • Bio-Rad Laboratories, Inc.  
  • Ortho Clinical Diagnostics  
  • DiaSorin S.p.A.  
  • Beckman Coulter, Inc. (a subsidiary of Danaher Corporation)  
  • Quidel Corporation  

Recent Developments

  • In October 2024, a proof-of-concept precision medicine clinical trial was launched by the National Institutes of Health (NIH) to test new treatment combinations targeting specific genetic changes in the cancer cells of people with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).
  • In January 2024, a global leader in science-based nutrition, Abbott, of its new PROTALITY™ brand. This is the first product in this line to support the growing number of adults interested in pursuing weight loss while maintaining good nutrition and muscle mass in bone-related diseases.  

Segments Covered in the Report

By Product

  • Assay or Consumables 
  • Instruments

By Technology

  • Clinical Laboratory Improvement Amendments (CLIA),  
  • Enzyme-linked immunosorbent assay (ELISA)  
  • Other tests.

By Application

  • Vitamin D Testing 
  • Bone Metabolism

By End User

  • Hospitals 
  • Clinics 
  • Laboratory Diagnostics

By Geography

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East and Africa

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global bone metabolism tests market size is expected to grow from USD 2.91 billion in 2024 to USD 6.02 billion by 2034.

The bone metabolism tests market is anticipated to grow at a CAGR of 7.53% between 2025 and 2034.

The major players operating in the bone metabolism tests market are F. Hoffmann-La Roche AG, Abbott Laboratories, Siemens Healthineers, Bio-Rad Laboratories, Inc., Ortho Clinical Diagnostics, DiaSorin S.p.A., Beckman Coulter, Inc. (a subsidiary of Danaher Corporation), Quidel Corporation, and Others..

The driving factors of the bone metabolism tests market are the increasing demand for more efficient and sustainable solutions across various industries, changing consumer preferences, and rising technological advancements are expected to drive market growth.

North America region will lead the global bone metabolism tests market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Meet the Team

Deepa Pandey, one of our esteemed authors, plays a crucial role in shaping the high-quality content that defines our research reports. Deepa holds a Master's in Pharmacy with a specialization in Pharmaceutical Quality Assurance, equipping her with an in-depth understanding of the healthcare industry's regulatory, quality, and operational nuances. With 2+ years of experience in market research, Deepa has made

Learn more about Deepa Pandey

With over 14 years of experience, Aditi is the powerhouse responsible for reviewing every piece of data and content that passes through our research pipeline. She is not just an expert—she’s the linchpin that ensures the accuracy, relevance, and clarity of the insights we deliver. Aditi’s broad expertise spans multiple sectors, with a keen focus on ICT, automotive, and various other cross-domain industries.

Learn more about Aditi Shivarkar

Related Reports